Diabetech - Diabetes Tech, Research, News He Built the App Diabetes Tech Was Missing
Dec 15, 2025
In this conversation, Pablo Medina, a medical graduate and software engineer diagnosed with LADA, shares his journey from misdiagnosis to innovation. He created an iPhone app to track insulin patch usage after struggling with existing diabetes tech. Pablo discusses his experiences with devices like InPen and Omnipod 5, highlighting the gaps he encountered. He reveals the challenges of app development and advocates for better CGM interoperability. His story is a testament to how patient-driven solutions can shape diabetes technology.
AI Snips
Chapters
Transcript
Episode notes
Misdiagnosis And LADA Relief
- Pablo was initially diagnosed as type 2 in Cuba after a high glucose reading and treated with metformin for about a year and a half.
- He later got the LADA (type 1.5) diagnosis in the U.S., which felt like a relief because it explained his sudden need for insulin.
Switching To A Smart Insulin Pen
- Pablo started using the InPen after his LADA diagnosis because it offered a calculator and logged insulin doses automatically.
- He found the InPen helpful for half-unit dosing and seeing insulin-on-board despite Dexcom integration delays.
Why He Chose An Insulin Patch
- Pablo chose the Cequr Simplicity patch because it offered discreteness and freedom from carrying pens while keeping manual control.
- He saw it as a middle ground to learn insulin effects before committing to a full pump.